Close Menu

NEW YORK – Invitae announced on Sunday preliminary 2019 revenues of around $216 million, representing 45 percent growth over $147.7 million the prior year but falling short of the consensus Wall Street estimate of $219.9 million and short of its own annual revenue projections of $220 million.  

The company said testing volume grew 60 percent year over year to more than 482,000 samples compared to 303,000 samples in 2018. The company had previously projected that it would accession more than 500,000 samples in 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.